Enzyme ImmunoAssay (ELISA) for the qualitative and/or semi quantitative determination of IgG antibodies to Mycobacterium tuberculosis.

Regulatery Status: CE
Catalog No Size
Product Catalog No: MTBG Pack Size: 96 Tests

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Summary

Mycobacterium tuberculosis (MTB) is a fastidious, slowlygrowing, strictly aerobic bacterium with a complex cell wall composed of peptide-glycans and many complex long-chain lipids.

Tuberculosis remains one of the most common and deadly diseases throughout the world. In the past 10 years there has been a resurgence of tuberculosis in old-world countries, also due to new infections (HIV) and immigration.

In the diagnosis of Tuberculosis and in the follow-up of infected patients, ELISA for antibodies may be useful to provide information on the immunological status of the patient, in addition to Nucleic Acid Tests (or NATs) able to determine the presence of the bacterium itself.

Test Principle

Microplates are coated with a chimeric recombinant antigen bearing the most immunogenic epitopes of MTB.

The solid phase is first treated with the diluted sample and anti MTB IgG are captured, if present, by the antigens coated on the microplate.

After washing out all the other components of the sample, in the 2nd incubation bound anti MTB IgG antibodies are detected by the addition of polyclonal specific anti hIgG antibodies, labeled with peroxidase (HRP).

The enzyme captured on the solid phase, acting on the substrate/chromogen mixture, generates an optical signal that is proportional to the amount of anti MTB IgG antibodies present in the sample.

IgG in the sample may therefore be semi quantitated in arbU/ml by means of its S/Co value and a calibration curve.

Order Enquiry

Order Enquiry Form

References
  1. Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology, 4th ed., McGraw Hill. ISBN 0-8385-8529-9.
  2. Cole ST; Brosch R; Parkhill J; et al. (1998). “Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.”. Nature 393: 537–544.
  3. Camus JC; Pryor MJ; Medigue C; Cole ST. (148). “Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv”. Microbiology 2002: 2967–2973.
  4. Flowers T (1995). “Quarantining the noncompliant TB patient: catching the “Red Snapper””. Journal of health and hospital law : a publication of the American Academy of Hospital Attorneys of the American Hospital Association 28 (2): == h == 95-105. PMID 10141473.
  5. Madigan, Michael; Martinko, John (editors) (2005). Brock Biology of Microorganisms, 11th ed., Prentice Hall. ISBN 0-13-144329-1.
Enquiry